353 related articles for article (PubMed ID: 8776723)
1. Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10.
Dey BR; Frick K; Lopaczynski W; Nissley SP; Furlanetto RW
Mol Endocrinol; 1996 Jun; 10(6):631-41. PubMed ID: 8776723
[TBL] [Abstract][Full Text] [Related]
2. Non-SH2 domains within insulin receptor substrate-1 and SHC mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor I receptor.
Craparo A; O'Neill TJ; Gustafson TA
J Biol Chem; 1995 Jun; 270(26):15639-43. PubMed ID: 7541045
[TBL] [Abstract][Full Text] [Related]
3. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.
Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T
Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA; Surmacz E
Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways.
Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M
Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504
[TBL] [Abstract][Full Text] [Related]
6. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.
Kim B; Cheng HL; Margolis B; Feldman EL
J Biol Chem; 1998 Dec; 273(51):34543-50. PubMed ID: 9852124
[TBL] [Abstract][Full Text] [Related]
7. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a direct interaction between insulin receptor substrate-1 and Shc.
Kasus-Jacobi A; Perdereau D; Tartare-Deckert S; Van Obberghen E; Girard J; Burnol AF
J Biol Chem; 1997 Jul; 272(27):17166-70. PubMed ID: 9202037
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system.
Tartare-Deckert S; Sawka-Verhelle D; Murdaca J; Van Obberghen E
J Biol Chem; 1995 Oct; 270(40):23456-60. PubMed ID: 7559507
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
[TBL] [Abstract][Full Text] [Related]
11. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.
Sasaoka T; Ishihara H; Sawa T; Ishiki M; Morioka H; Imamura T; Usui I; Takata Y; Kobayashi M
J Biol Chem; 1996 Aug; 271(33):20082-7. PubMed ID: 8702728
[TBL] [Abstract][Full Text] [Related]
12. Differential modulation of the tyrosine phosphorylation state of the insulin receptor by IRS (insulin receptor subunit) proteins.
Solow BT; Harada S; Goldstein BJ; Smith JA; White MF; Jarett L
Mol Endocrinol; 1999 Oct; 13(10):1784-98. PubMed ID: 10517679
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells.
Kim B; Leventhal PS; White MF; Feldman EL
Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424
[TBL] [Abstract][Full Text] [Related]
14. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
Mur C; Valverde AM; Kahn CR; Benito M
Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
[TBL] [Abstract][Full Text] [Related]
15. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
Valverde AM; Lorenzo M; Pons S; White MF; Benito M
Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931
[TBL] [Abstract][Full Text] [Related]
16. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues.
Thirone AC; Carvalho CR; Saad MJ
Endocrinology; 1999 Jan; 140(1):55-62. PubMed ID: 9886807
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis.
Sasaoka T; Ishiki M; Wada T; Hori H; Hirai H; Haruta T; Ishihara H; Kobayashi M
Endocrinology; 2001 Dec; 142(12):5226-35. PubMed ID: 11713219
[TBL] [Abstract][Full Text] [Related]
19. Insulin signals to prenyltransferases via the Shc branch of intracellular signaling.
Goalstone ML; Leitner JW; Berhanu P; Sharma PM; Olefsky JM; Draznin B
J Biol Chem; 2001 Apr; 276(16):12805-12. PubMed ID: 11278505
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of insulin-stimulated mitogen-activated protein kinase signaling by Grb10.
Langlais P; Dong LQ; Ramos FJ; Hu D; Li Y; Quon MJ; Liu F
Mol Endocrinol; 2004 Feb; 18(2):350-8. PubMed ID: 14615605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
